Submissions received: Changes to a number of definitions and the scope of the medical device regulatory framework in Australia
The TGA thanks respondents who provided a submission in response to the public consultation paper Changes to a number of definitions and the scope of the medical device regulatory framework in Australia.
This consultation was related to the implementation of the Australian Government Response to the Review of Medicines and Medical Devices Regulation (MMDR), in particular Recommendation 20 that prescribes that the regulation of medical devices in Australia, wherever possible and appropriate, should be aligned with the European Union (EU) framework.
A total of twenty-one (21) submissions were received.
Summary of feedback
This consultation invited respondents to provide feedback on proposed changes to a number of definitions underpinning the medical devices regulatory framework, and proposed changes to the regulation of some products without a medical purpose to include them into the medical devices regulatory framework.
Specifically, the TGA proposed to:
- align the Australian regulatory definitions with the terminology used in the EU Regulation on medical devices 2017/745 (EU MD Regulation); and
- broaden the range of products included within the scope of the Australian medical device regulations, to align with Annex XVI of the EU MD Regulations.
There was general support for the proposals to align the Australian regulatory requirements with the EU MD Regulation. However, some respondents had specific concerns and comments about both proposals.
- Proposed alignment of the Australian definitions with the EU MD Regulation
Submissions were broadly supportive for the proposal to align the Australian definitions with those definitions in the EU MD Regulation. However, a few respondents expressed concern about the proposed alignment of the terms 'medical device', 'accessory' and 'lay person'. For example, two respondents did not support the proposed changes to the definition of 'medical device', in particular inclusion of reference to 'products specifically intended for the cleaning, disinfection or sterilisation of devices'. However, this category of products is already considered to be an accessory to a medical device and as such are currently regulated as medical devices in Australia.
Other respondents raised issues with the proposal not to align with the EU definitions related to post-market activities. The TGA will undertake further consultation on post market related definitions as part of the separate post-market reforms consultation process during 2020.
- Proposed regulation of products without a medical purpose
There was general support for the regulation of products without a medical purpose, with strong support for the regulation of decorative contact lenses and brain stimulation devices that do not have a stated medical purpose but are being used (or could be seen from a consumer's perspective as being used) for a medical purpose. However, there was some opposition to the regulation of products for beauty therapy, such as lasers and personal intense pulsed light (IPL) devices, with recommendations from respondents for further consultation.
Where to from here?
The feedback from the consultation will continue to inform the work to develop the proposed regulatory amendments.
The TGA intends to proceed with recommending to the Government to align some Australian regulatory definitions with the EU MD Regulations, such as for 'medical device', 'accessory', 'single use', 'user', 'reusable surgical instrument'. Some proposed definitions are related to other consultations and will be considered in the context of these consultations prior to considering further regulatory amendments (e.g. proposed changes to medical device essential principles for safety and performance).
The TGA will undertake further discussions with targeted stakeholders about the proposed regulation of products for beauty therapy, such as lasers and IPL devices, prior to considering further regulatory amendments.
All submissions that gave permission to be published on the TGA website are now available below in PDF format.
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open it from there.
- Consultation submission: AbbVie Pty Ltd (pdf,2.43Mb)*
- Consultation submission: Accord Australasia (pdf,119kb)
- Consultation submission: AusBiotech Ltd (pdf,164kb)
- Consultation submission: Australasian Sleep Association (pdf,167kb)
- Consultation submission: Australian Dental Industry Association (pdf,1Mb)*
- Consultation submission: Australian Self-Medication Industry Ltd (pdf,207kb)
- Consultation submission: Cochlear Limited (pdf,44kb)
- Consultation submission: Consumers Health Forum of Australia (pdf,231kb)
- Consultation submission: National Measurement Institute (pdf,285kb)
- Consultation submission: NSW Government Clinical Excellence Commission (pdf,81kb)
- Consultation submission: Private Healthcare Australia (pdf,374kb)
- Consultation submission: Procter & Gamble Australia (pdf,189kb)